IQ-AI Limited (GB:IQAI) has released an update.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
IQ-AI Limited’s subsidiary, Imaging Biometrics, has renewed its distribution agreement with GE HealthCare to expand the reach of its advanced imaging solutions. The agreement will see GE HealthCare selling IB Neuro and IB Delta T1 platforms, which are vital for brain tumor diagnosis and treatment monitoring. This collaboration aims to expedite the adoption of these innovative tools, enhancing healthcare providers’ capabilities and benefiting patients worldwide.
For further insights into GB:IQAI stock, check out TipRanks’ Stock Analysis page.
